Skip to content
10-Q

Quarterly Report

Harvard Apparatus Regenerative Technology, Inc. HRGN

0001437749-26-016761

← back to feed
Filed
May 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 17.58M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$937K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$758K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $419K
Cash And Equivalents Q1 2026 · Dec 31, 2025 $1.35M
Stockholders Equity Q1 2026 · Mar 31, 2026 $92K
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.06M
Stockholders Equity Q1 2026 · Mar 31, 2025 $2.05M
Stockholders Equity Q1 2026 · Dec 31, 2024 $3.22M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.65M
Current Liabilities Q1 2026 · Dec 31, 2025 $1.53M
Total Liabilities Q1 2026 · Mar 31, 2026 $1.71M
Total Liabilities Q1 2026 · Dec 31, 2025 $1.62M
Current Assets Q1 2026 · Mar 31, 2026 $873K
Current Assets Q1 2026 · Dec 31, 2025 $1.83M
Total Assets Q1 2026 · Mar 31, 2026 $1.8M
Total Assets Q1 2026 · Dec 31, 2025 $2.68M
Eps Basic Q1 2026 · Mar 31, 2026 −$0.09
Eps Basic Q1 2026 · Mar 31, 2025 −$0.10
Rd Expense Q1 2026 · Mar 31, 2026 $563K
Rd Expense Q1 2026 · Mar 31, 2025 $601K
Net Income Q1 2026 · Mar 31, 2026 −$1.6M
Net Income Q1 2026 · Mar 31, 2025 −$1.66M
Operating Income Q1 2026 · Mar 31, 2026 −$1.61M
Operating Income Q1 2026 · Mar 31, 2025 −$1.67M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $206K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $33K
Revenue Q1 2026 · Mar 31, 2026 $226K
Revenue Q1 2026 · Mar 31, 2025 $45K